Deep, qualified up coming-technology sequencing has discovered that subclonal mutations (i.e., Individuals current in just a fraction of tumor cells) may be detected for all driver genes and so are associated with rapid ailment progression and inadequate result.11–13 This is especially appropriate for TP53Not all individuals with CLL involve ther